Detailed information on the research project currently underway. We encourage you to bookmark these pages and check back often. Updates will be added periodically with new information on status, newly-released data, and clinical trial results. Back to New Hair Loss Research Pipeline
Breezula is a steroidal anti-androgen for the treatment of Androgenetic Alopecia. It is topically delivered to the scalp to reduce the miniaturization process. Breezula acts at the cutaneous level of the scalp by blocking the DHT interaction with androgen receptors that are located in the hair follicle.
Unlike other DHT-inhibitors and Antiandrogens, Breezula shouldn’t interfere with the hormonal function, nor the androgen profile patients. This should make it a unique compound.
Innovative and Differentiated Medical Dermatology Products